A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease
Clinical trial NCT06225973 · UNKNOWN
Trial details
- NCT number
- NCT06225973
- Sponsor
- Telios Pharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-06
- Primary completion
- 2024-12-01
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.